Sleep-improving mechanisms of Jiu Wei Bu Xue Oral Liquid on regulating Glu/GABA balance in insomnia rats based on network pharmacology and experimental verification
10.16438/j.0513-4870.2022-0878
- VernacularTitle:基于整合网络药理学和实验验证探究九味补血口服液调控Glu/GABA动态平衡改善失眠大鼠睡眠机制的研究
- Author:
Jie WEI
1
;
Xiao-dong LAN
2
;
Dong-mei LI
1
;
Jun-hui HE
3
;
Zhen MENG
2
;
Dong-mei WEI
1
;
Yi LI
1
;
Fu-quan PENG
2
;
Gui-ning WEI
1
;
Ruo-gan HUANG
2
Author Information
1. Guangxi Institute of Chinese Medicine and Pharmaceutical Science, Nanning 530022, China
2. Guangxi Baiyunshan Yingkang Pharmaceutical Co., Ltd., Nanning 530002, China
3. Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Nanning 530022, China
- Publication Type:Research Article
- Keywords:
Jiu Wei Bu Xue Oral Liquid;
insomnia;
para-chlorophenylalanine;
pentobarbital sodium;
network pharmacology;
molecular docking;
italic>γ-aminobutyrate
- From:
Acta Pharmaceutica Sinica
2023;58(6):1484-1495
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to investigate the mechanism of Jiu Wei Bu Xue Oral Liquid on insomnia rats combining the methods of network pharmacology, molecular docking and experimental verification. UPLC-Q-TOF-MS/MS method and TCMIP, TCMSP databases were used to collect the ingredients and targets of Jiu Wei Bu Xue Oral Liquid. Protein-protein interactions and network analysis were performed to screen the key network targets and putative active ingredients of Jiu Wei Bu Xue Oral Liquid in treatment of insomnia, and then following by biological function and KEGG pathway analysis. Then binding ability for key network targets and putative active ingredients were predicted with molecular docking. The prediction targets were validated in para-chlorophenylalanine (PCPA) induced insomnia rats with administration of Jiu Wei Bu Xue Oral Liquid (2, 4, 8 mL·kg-1) for 7 days. Pentobarbital sodium induced sleeping test were performed to evaluate the synergistic sleep-aiding effect of Jiu Wei Bu Xue Oral Liquid. Then glutamic acid (Glu), γ-aminobutyrate (GABA) content and glutamate decarboxylase 1 (GAD67) activity in hypothalamus or hippocampus were evaluated, and the expressions of GAD67, γ-aminobutyric acid receptor subunit α1 (GABRA1) and γ-aminobutyric acid receptor subunit β2 (GABRB2) in hippocampus were detected by qRT-PCR and Western blot methods. Animal experiments were approved by the Institutional Committee on Animal Care of Guangxi Institute of Chinese Medicine & Pharmaceutical Science (the number of permission: 2022060802). Results showed that 16 key network targets and 16 putative active ingredients were obtained by analyzing the herbs-ingredients-targets network of Jiu Wei Bu Xue Oral Liquid in treatment of insomnia. Network pharmacology and molecular docking all indicated these active ingredients, for example atractylenolide Ⅲ, showed better binding ability with GABRA1 and GABRB2. Animal study indicated that, compared to PCPA-induced insomnia model, Jiu Wei Bu Xue Oral Liquid remarkably shortened the sleeping latency and increased the sleeping duration, increased GAD67 activity and the production of GABA in hippocampus of insomnia rats, as well as the expressions of GAD67, GABRA1 and GABRB2, while decreased Glu content in hypothalamus, leading to decreasing of Glu/GABA ratio and recovery of Glu-GABA balance. These results indicated that Jiu Wei Bu Xue Oral Liquid improved insomnia symptoms and helped maintain the Glu-GABA balance within hypothalamus and hippocampus, and reduced the excitatory neurotoxicity within brain. The mechanism may due to the elevation of GAD67 expression and enzyme activity, and the enhancement of type-A GABA receptor (GABAAR)-mediated neurons inhibition.
